China News Service, Beijing, November 27. With the increasing incidence of metabolic diseases such as hypertension and diabetes, patients with chronic end-stage renal disease have gradually increased, and the demand for dialysis has increased.
China’s first expert consensus on automated peritoneal dialysis was released recently. Experts pointed out that they hope to use the release of this consensus to promote the awareness and application rate of automated peritoneal dialysis (APD) treatment and increase the incidence of end-stage renal disease (ESRD) patients in my country. Treatment rate improves the quality of life of dialysis patients.
China is a major country with chronic kidney disease, with an adult prevalence rate of 10.8%.
End-stage renal disease refers to the end stage of various chronic kidney diseases.
According to the epidemiological survey results, the total number of patients with end-stage renal disease in China is about 1 to 2 million, but as of the end of 2019, the number of patients (including hemodialysis and peritoneal dialysis) registered in the National Blood Purification Case Information Registration System (CNRDS) Only 735,000 people.
The "Chinese Expert Consensus on Automated Peritoneal Dialysis" (hereinafter referred to as the "Consensus") jointly compiled by the Nephrology Branch of the Chinese Medical Doctor Association and the National Nephrology Quality Control Center (hereinafter referred to as the "Consensus") was released recently.
This is China's first expert consensus on automated peritoneal dialysis, aiming to improve the standardization level and treatment quality of automated peritoneal dialysis clinical treatment.
According to the recommendations of the International Association of Peritoneal Dialysis in 2000 and the European Best Practice Guidelines for Peritoneal Dialysis in 2005, automated peritoneal dialysis is suitable for peritoneal dialysis patients with ultrafiltration failure in high transport state, and can reduce their death and technical risks; it has a strong ability to remove small molecule solutes ; The frequency of manual fluid exchange is reduced, and the risk of infection is reduced; the dialysis dose is easy to adjust, and the labor cost is reduced.
In recent years, with the emergence of automated peritoneal dialysis machines and remote patient monitoring (RPM) systems with Internet functions, automated peritoneal dialysis treatment has entered the era of remote intelligence.
For patients, the peritoneal dialysis remote monitoring platform can provide regular health education and remotely obtain doctor's operating instructions.
For medical care, remote monitoring is used to implement timely, full-process and full-cycle management, improve treatment compliance, reduce the frequency of patient outpatient follow-up, and save medical resources.
In terms of epidemic prevention and control, home-based automated peritoneal dialysis can prevent dialysis patients with relatively low immunity from frequent trips to the hospital and perform dialysis treatment in a relatively isolated space.
At present, the application of automated peritoneal dialysis in many European and American countries has been very extensive. The use rate of automated peritoneal dialysis in the United States, Canada, Australia, and the United Kingdom exceeds 50%.
However, the use of automated peritoneal dialysis in China started late and the regional development is uneven. According to the 2019 CNRDS report, the use rate of automated peritoneal dialysis in China is only 1.9%.
Chen Xiangmei, academician of the Chinese Academy of Engineering, president of the Chinese Society of Integrative Medicine, and president of the Nephrology Branch of the Chinese Medical Doctor Association, pointed out that patients currently undergoing dialysis have put forward higher and higher requirements for their quality of life and the ability to return to society. The release of this consensus promotes the awareness and application rate of automated peritoneal dialysis treatment, improves the treatment rate of end-stage renal disease patients in my country, and improves the quality of life of dialysis patients.
(Finish)